SE406010B - Forfarande och medel for bestemning av beta-laktamasaktivitet - Google Patents

Forfarande och medel for bestemning av beta-laktamasaktivitet

Info

Publication number: SE406010B
Authority: SE; Sweden
Prior art keywords: solution; process according; water; formula; isomer
Prior art date: 1971-10-07

Application number

SE7212963A

Other languages

English (en)

Swedish (sv)

Inventor

C H O'callaghan

J C Clark

J Kennedy

S M Kirby

A G Long

A Morris

A H Shingler

N G Weir

Original Assignee

Glaxo Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-10-07

Filing date

1972-10-06

Publication date

1979-01-15

1972-10-06 Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd

1979-01-15 Publication of SE406010B publication Critical patent/SE406010B/sv

Links

238000000034 method Methods 0.000 title claims description 24
230000000694 effects Effects 0.000 title claims description 14
-1 amino, formamido Chemical group 0.000 claims description 46
150000001875 compounds Chemical class 0.000 claims description 38
238000012360 testing method Methods 0.000 claims description 38
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
239000000463 material Substances 0.000 claims description 32
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
102000006635 beta-lactamase Human genes 0.000 claims description 20
150000002148 esters Chemical class 0.000 claims description 20
239000002904 solvent Substances 0.000 claims description 20
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
150000003839 salts Chemical class 0.000 claims description 14
108090000204 Dipeptidase 1 Proteins 0.000 claims description 13
239000002250 absorbent Substances 0.000 claims description 11
230000002745 absorbent Effects 0.000 claims description 11
239000000126 substance Substances 0.000 claims description 11
229920001817 Agar Polymers 0.000 claims description 7
239000008272 agar Substances 0.000 claims description 7
239000003960 organic solvent Substances 0.000 claims description 7
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
239000000523 sample Substances 0.000 claims description 7
230000001580 bacterial effect Effects 0.000 claims description 6
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
125000004093 cyano group Chemical group *C#N 0.000 claims description 5
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
125000003118 aryl group Chemical group 0.000 claims description 4
229910052739 hydrogen Inorganic materials 0.000 claims description 4
239000001257 hydrogen Substances 0.000 claims description 4
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 3
239000012472 biological sample Substances 0.000 claims description 3
239000001913 cellulose Substances 0.000 claims description 3
229920002678 cellulose Polymers 0.000 claims description 3
230000021615 conjugation Effects 0.000 claims description 3
125000002541 furyl group Chemical group 0.000 claims description 3
238000009630 liquid culture Methods 0.000 claims description 3
125000001624 naphthyl group Chemical group 0.000 claims description 3
125000004076 pyridyl group Chemical group 0.000 claims description 3
125000001544 thienyl group Chemical group 0.000 claims description 3
125000003456 2,6-dinitrophenyl group Chemical group [H]C1=C([H])C(=C(*)C(=C1[H])[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 2
125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 2
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 2
229910052783 alkali metal Inorganic materials 0.000 claims 1
150000001340 alkali metals Chemical group 0.000 claims 1
150000003863 ammonium salts Chemical class 0.000 claims 1
239000004599 antimicrobial Substances 0.000 claims 1
238000002512 chemotherapy Methods 0.000 claims 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 138
239000000243 solution Substances 0.000 description 132
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 94
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 66
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 59
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
239000007787 solid Substances 0.000 description 34
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
239000000203 mixture Substances 0.000 description 31
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 29
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 24
238000001228 spectrum Methods 0.000 description 24
239000000741 silica gel Substances 0.000 description 23
229910002027 silica gel Inorganic materials 0.000 description 23
229940073584 methylene chloride Drugs 0.000 description 22
239000003480 eluent Substances 0.000 description 21
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
239000006260 foam Substances 0.000 description 18
239000011780 sodium chloride Substances 0.000 description 17
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
239000003208 petroleum Substances 0.000 description 13
238000003756 stirring Methods 0.000 description 13
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 12
239000002253 acid Substances 0.000 description 11
239000003153 chemical reaction reagent Substances 0.000 description 11
238000004587 chromatography analysis Methods 0.000 description 11
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
239000012071 phase Substances 0.000 description 10
238000000354 decomposition reaction Methods 0.000 description 9
239000012074 organic phase Substances 0.000 description 9
238000001704 evaporation Methods 0.000 description 8
230000008020 evaporation Effects 0.000 description 8
239000000499 gel Substances 0.000 description 8
230000008018 melting Effects 0.000 description 8
238000002844 melting Methods 0.000 description 8
239000000725 suspension Substances 0.000 description 8
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
108020004256 Beta-lactamase Proteins 0.000 description 7
125000003277 amino group Chemical group 0.000 description 6
ZILXIZUBLXVYPI-UHFFFAOYSA-N 2,4-dinitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C([N+]([O-])=O)=C1 ZILXIZUBLXVYPI-UHFFFAOYSA-N 0.000 description 5
241000894006 Bacteria Species 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
239000008363 phosphate buffer Substances 0.000 description 5
229930182555 Penicillin Natural products 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
229930186147 Cephalosporin Natural products 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
230000000844 anti-bacterial effect Effects 0.000 description 3
230000005540 biological transmission Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
229940124587 cephalosporin Drugs 0.000 description 3
150000001780 cephalosporins Chemical class 0.000 description 3
239000003610 charcoal Substances 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
238000002329 infrared spectrum Methods 0.000 description 3
229940049954 penicillin Drugs 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
125000001424 substituent group Chemical group 0.000 description 3
LHNIIDJCEODSHA-YLJYHZDGSA-N (6r,7r)-3-[2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C=CC=1C(=CC(=CC=1)[N+]([O-])=O)[N+]([O-])=O)C(=O)CC1=CC=CS1 LHNIIDJCEODSHA-YLJYHZDGSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
WZJQAPHHXNBOGN-WIYYLYMNSA-N C(#N)C1=CC=C(C=CC=2CS[C@H]3N(C2C(=O)O)C([C@H]3NC(CC=3SC=CC3)=O)=O)C=C1 Chemical compound C(#N)C1=CC=C(C=CC=2CS[C@H]3N(C2C(=O)O)C([C@H]3NC(CC=3SC=CC3)=O)=O)C=C1 WZJQAPHHXNBOGN-WIYYLYMNSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
ZDBDKZVNXSQOQV-CYTLCNBWSA-N benzhydryl (6R,7R)-3-[2-(4-nitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1(=CC=CC=C1)C(C1=CC=CC=C1)OC(=O)C1=C(CS[C@H]2N1C([C@H]2NC(CC=1SC=CC=1)=O)=O)C=CC1=CC=C(C=C1)[N+](=O)[O-] ZDBDKZVNXSQOQV-CYTLCNBWSA-N 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
150000007942 carboxylates Chemical class 0.000 description 2
150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
238000006317 isomerization reaction Methods 0.000 description 2
150000003951 lactams Chemical group 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000012452 mother liquor Substances 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
239000003973 paint Substances 0.000 description 2
150000002960 penicillins Chemical class 0.000 description 2
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
239000000047 product Substances 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
239000012258 stirred mixture Substances 0.000 description 2
CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
238000001665 trituration Methods 0.000 description 2
MGXQQQKRQHLVFR-YLJYHZDGSA-N (6R,7R)-3-[2-(4-nitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound [N+](=O)([O-])C1=CC=C(C=CC=2CS[C@H]3N(C=2C(=O)O)C([C@H]3NC(CC=2SC=CC=2)=O)=O)C=C1 MGXQQQKRQHLVFR-YLJYHZDGSA-N 0.000 description 1
ZKALETLKESSQCU-NQPNHJOESA-N (6r)-7-formamido-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2C(NC=O)C(=O)N12 ZKALETLKESSQCU-NQPNHJOESA-N 0.000 description 1
DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
SMJRBWINMFUUDS-UHFFFAOYSA-N 2-thienylacetic acid Chemical compound OC(=O)CC1=CC=CS1 SMJRBWINMFUUDS-UHFFFAOYSA-N 0.000 description 1
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
YPXQSGWOGQPLQO-UHFFFAOYSA-N 5-nitro-1,3-dihydrobenzimidazole-2-thione Chemical compound [O-][N+](=O)C1=CC=C2N=C(S)NC2=C1 YPXQSGWOGQPLQO-UHFFFAOYSA-N 0.000 description 1
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241000194108 Bacillus licheniformis Species 0.000 description 1
HNNIWKQLJSNAEQ-UHFFFAOYSA-N Benzydamine hydrochloride Chemical compound Cl.C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 HNNIWKQLJSNAEQ-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
QKFLDLQQZNPGEL-SHIDIUGESA-N C1=CC=C(C=C1)C(C2C(=C(N3[C@H]([S@]2=O)[C@@H](C3=O)NC(=O)CC4=CC=CS4)C(=O)O)C=CC5=C(C=C(C=C5)[N+](=O)[O-])[N+](=O)[O-])C6=CC=CC=C6 Chemical compound C1=CC=C(C=C1)C(C2C(=C(N3[C@H]([S@]2=O)[C@@H](C3=O)NC(=O)CC4=CC=CS4)C(=O)O)C=CC5=C(C=C(C=C5)[N+](=O)[O-])[N+](=O)[O-])C6=CC=CC=C6 QKFLDLQQZNPGEL-SHIDIUGESA-N 0.000 description 1
BMPTZDPQTDWUDU-UHFFFAOYSA-N ClC(C(=O)ON=C1/C(C=CC=C1)CC(=O)Cl)Cl Chemical compound ClC(C(=O)ON=C1/C(C=CC=C1)CC(=O)Cl)Cl BMPTZDPQTDWUDU-UHFFFAOYSA-N 0.000 description 1
101710200331 Cytochrome b-245 chaperone 1 Proteins 0.000 description 1
102100037186 Cytochrome b-245 chaperone 1 Human genes 0.000 description 1
101710119396 Cytochrome b-245 chaperone 1 homolog Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
101100440640 Drosophila melanogaster conu gene Proteins 0.000 description 1
241000588914 Enterobacter Species 0.000 description 1
241000588697 Enterobacter cloacae Species 0.000 description 1
241001505295 Eros Species 0.000 description 1
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
241000588915 Klebsiella aerogenes Species 0.000 description 1
241000556720 Manga Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
VPGLEVVYHTZEKM-KAODMTDESA-N N#CC1=CC=C(C=CC(CS[C@@H]2[C@@H]3NC(CC4=CC=CS4)=O)=C(C(OC(C4=CC=CC=C4)C4=CC=CC=C4)=O)N2C3=O)C=C1 Chemical compound N#CC1=CC=C(C=CC(CS[C@@H]2[C@@H]3NC(CC4=CC=CS4)=O)=C(C(OC(C4=CC=CC=C4)C4=CC=CC=C4)=O)N2C3=O)C=C1 VPGLEVVYHTZEKM-KAODMTDESA-N 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
206010042496 Sunburn Diseases 0.000 description 1
ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
VMTUGOKMMLXERG-CYTLCNBWSA-N benzhydryl (6R,7R)-3-[2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1(=CC=CC=C1)C(C1=CC=CC=C1)OC(=O)C1=C(CS[C@H]2N1C([C@H]2NC(CC=1SC=CC=1)=O)=O)C=CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-] VMTUGOKMMLXERG-CYTLCNBWSA-N 0.000 description 1
ZAICNQLZQZZTCV-YIXXDRMTSA-N benzhydryl (6R,7R)-7-amino-3-[2-(2,4-dinitrophenyl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1(=CC=CC=C1)C(C1=CC=CC=C1)OC(=O)C1=C(CS[C@H]2N1C([C@H]2N)=O)C=CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-] ZAICNQLZQZZTCV-YIXXDRMTSA-N 0.000 description 1
125000003460 beta-lactamyl group Chemical group 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
125000006267 biphenyl group Chemical group 0.000 description 1
238000009835 boiling Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000002826 coolant Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
238000011161 development Methods 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
235000014103 egg white Nutrition 0.000 description 1
210000000969 egg white Anatomy 0.000 description 1
125000006575 electron-withdrawing group Chemical group 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
238000000227 grinding Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004922 lacquer Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
229910000403 monosodium phosphate Inorganic materials 0.000 description 1
235000019799 monosodium phosphate Nutrition 0.000 description 1
NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 1
239000011368 organic material Substances 0.000 description 1
239000005416 organic matter Substances 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
238000004816 paper chromatography Methods 0.000 description 1
230000007170 pathology Effects 0.000 description 1
ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000010453 quartz Substances 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000007142 ring opening reaction Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
150000003385 sodium Chemical class 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
229940001474 sodium thiosulfate Drugs 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
230000007306 turnover Effects 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2415/00—Assays, e.g. immunoassays or enzyme assays, involving penicillins or cephalosporins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Cephalosporin Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SE7212963A 1971-10-07 1972-10-06 Forfarande och medel for bestemning av beta-laktamasaktivitet SE406010B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB4679871A GB1408391A (en)	1971-10-07	1971-10-07	Cephalosporin compounds as reagents

Publications (1)

Publication Number	Publication Date
SE406010B true SE406010B (sv)	1979-01-15

Family

ID=10442642

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7212963A SE406010B (sv)	1971-10-07	1972-10-06	Forfarande och medel for bestemning av beta-laktamasaktivitet

Country Status (11)

Country	Link
US (1)	US3830700A (fr)
JP (1)	JPS5618197B2 (fr)
BE (1)	BE789817A (fr)
CH (1)	CH609458A5 (fr)
DE (1)	DE2249165C2 (fr)
DK (1)	DK143657C (fr)
FR (1)	FR2155655A5 (fr)
GB (1)	GB1408391A (fr)
IE (1)	IE36744B1 (fr)
NL (1)	NL182896C (fr)
SE (1)	SE406010B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4095021A (en) *	1973-12-21	1978-06-13	Glaxo Laboratories Limited	3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US3983113A (en) *	1975-08-15	1976-09-28	Syntex (U.S.A.) Inc.	Cephalosporin type antibacterials
US4049806A (en) *	1975-08-15	1977-09-20	Syntex (U.S.A.) Inc.	Cephalosporin type antibacterials
US4112087A (en) *	1976-11-04	1978-09-05	Syntex (U.S.A.) Inc.	Cephalosporin type antibacterials having a substituted propenyl group in the 3-position
US4234683A (en) *	1978-11-24	1980-11-18	Mcmillan William A	Beta-lactamase diagnostic product and method
DE2916433A1 (de) *	1979-04-24	1980-11-13	Hoechst Ag	Chromophore cephalosporine und verfahren zu ihrer herstellung
ZA806977B (en) *	1979-11-19	1981-10-28	Fujisawa Pharmaceutical Co	7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006889A1 (de) *	1980-02-23	1981-09-10	Hoechst Ag, 6000 Frankfurt	Chromogene cephalosporine und verfahren zu ihrer herstellung
IL59723A (en) *	1980-03-27	1983-05-15	Teva Pharma	Determination of antibacterial agents
DE3019451A1 (de) *	1980-05-21	1981-11-26	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren und reagens zur bestimmung von (beta) -lactamasen
WO1982003090A1 (fr) *	1981-03-03	1982-09-16	James Richard	Procede et 'kit' d'identification de lactamases beta
US4713328A (en) *	1981-09-30	1987-12-15	Yolken Robert H	Microbial Enzyme assays
GB2128737B (en) *	1982-10-07	1986-02-05	Beecham Group Plc	Antibiotic susceptibility test material
ZA84584B (en) *	1983-01-28	1984-09-26	Bristol Myers Co	Substituted vinyl cephalosporins
US4520022A (en) *	1983-01-28	1985-05-28	Bristol-Myers Company	Substituted vinyl cephalosporins
US4558123A (en) *	1983-07-22	1985-12-10	Eli Lilly And Company	3-Exomethylene cephalosporins
US4568637A (en) *	1983-08-10	1986-02-04	Whittaker M.A. Bioproducts, Inc.	Method of determining antibiotics in biological liquids
FR2570702B1 (fr) *	1984-09-27	1987-01-09	Sanofi Sa	Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
US4764462A (en) *	1985-08-23	1988-08-16	Georgetown University	Detectably labeled cephalosporin assay for beta-lactamase
US5338843A (en) *	1992-01-30	1994-08-16	Becton, Dickinson And Company	Fluorogenic and chromogenic β-lactamase substrates
CA2423328C (fr) *	2000-09-22	2010-01-12	Zenyaku Kogyo Kabushiki Kaisha	Compose cepheme et reactif de detection de beta-lactamase a large spectre, contenant ces composes
JP2004166694A (ja) *	2002-10-29	2004-06-17	Showa Yakuhin Kako Kk	β−ラクタマーゼ検出試薬組成物、検出キット及び検出方法
CN1729299A (zh) *	2002-10-29	2006-02-01	昭和药品化工株式会社	β－内酰胺酶检测试剂组合物、检测试剂盒及检测方法
FR2881755B1 (fr) *	2005-02-10	2012-11-30	Biomerieux Sa	Milieux pour la detection specifique de micro-organismes resistants
ES2645455T3 (es) *	2006-12-19	2017-12-05	Becton, Dickinson And Company	Medio cromogénico para detección e identificación de enterococos resistentes a vancomicina y procedimiento asociado
CA2935651A1 (fr) *	2007-10-09	2009-04-16	Gladius Pharmaceuticals Corporation	Inhibiteurs de beta-lactamase a large spectre
EP3441071A1 (fr)	2013-03-12	2019-02-13	Gladius Pharmaceuticals Corporation	Céphalosporines dérivées
CN106083894B (zh) *	2016-06-14	2018-11-13	大连理工大学	头孢硝噻吩的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3769277A (en) *	1970-01-23	1973-10-30	Glaxo Lab Ltd	Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group

0
- BE BE789817D patent/BE789817A/fr not_active IP Right Cessation
1971
- 1971-10-07 GB GB4679871A patent/GB1408391A/en not_active Expired
1972
- 1972-10-03 US US00294649A patent/US3830700A/en not_active Expired - Lifetime
- 1972-10-06 CH CH1463172A patent/CH609458A5/xx not_active IP Right Cessation
- 1972-10-06 JP JP10233272A patent/JPS5618197B2/ja not_active Expired
- 1972-10-06 NL NLAANVRAGE7213595,A patent/NL182896C/xx not_active IP Right Cessation
- 1972-10-06 FR FR7235572A patent/FR2155655A5/fr not_active Expired
- 1972-10-06 SE SE7212963A patent/SE406010B/sv unknown
- 1972-10-06 DE DE2249165A patent/DE2249165C2/de not_active Expired
- 1972-10-06 IE IE1359/72A patent/IE36744B1/xx unknown
- 1972-10-06 DK DK494072A patent/DK143657C/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
CH609458A5 (fr)	1979-02-28
BE789817A (fr)	1973-04-06
DK143657B (da)	1981-09-21
NL182896C (nl)	1988-06-01
DE2249165A1 (de)	1973-04-26
US3830700A (en)	1974-08-20
FR2155655A5 (fr)	1973-05-18
GB1408391A (en)	1975-10-01
JPS4850787A (fr)	1973-07-17
NL7213595A (fr)	1973-04-10
JPS5618197B2 (fr)	1981-04-27
NL182896B (nl)	1988-01-04
IE36744L (en)	1973-04-07
DE2249165C2 (de)	1983-11-17
IE36744B1 (en)	1977-02-16
DK143657C (da)	1982-03-01

Publication	Publication Date	Title
SE406010B (sv)	1979-01-15	Forfarande och medel for bestemning av beta-laktamasaktivitet
Gadad et al.	2000	Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo [2, 1-b]-1, 3, 4-thiadiazole-2-sulfonamide derivatives
Mett et al.	1988	Outer membrane permeability and β-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants
US8940909B2 (en)	2015-01-27	Indicator platform
Hood et al.	1979	OLIVANIC ACIDS, A FAMILY OF β-LACTAM ANTIBIOTICS WITH β-LACTAMASE INHIBITORY PROPERTIES PRODUCED BY STREPTOMYCES SPECIES II. ISOLATION AND CHARACTERISATION OF THE OLIVANIC ACIDS MM 4550, MM 13902 AND MM 17880 FROM STREPTOMYCES OLIVACEUS
MATSUKUMA et al.	1989	Synthesis and biological evaluation of 3-chloro-1-carbacephem compounds
US4448880A (en)	1984-05-15	Detection of β-lactamase utilizing a chromophoric cephalosporin composition
US3207755A (en)	1965-09-21	Transformation products of cephalosporin c and derivatives thereof
Parish et al.	2009	Antisense-guided isolation and structure elucidation of pannomycin, a substituted cis-decalin from Geomyces pannorum
SE470259B (sv)	1993-12-20	Mellanprodukter till cefalosporiner
EP1325923B1 (fr)	2006-12-06	Composes cephemes et reactifs de detection de beta-lactamases a large spectre, contenant ces composes
Nascimento et al.	2021	Cephalothin: Review of characteristics, properties, and status of analytical methods
US3985742A (en)	1976-10-12	Process for preparing 3-hydroxymethyl cephalosporins
Murakami et al.	1981	1-Oxacephalosporins: enhancement of. beta.-lactam reactivity and antibacterial activity
US3219662A (en)	1965-11-23	Transformation products of cephalosporin c and derivatives thereof
US4302578A (en)	1981-11-24	Cephalosporin antibiotics
O'Callaghan	1978	Irreversible effects of serum proteins on beta-lactam antibiotics
US3941779A (en)	1976-03-02	Method for producing 2-(substituted thio)-3-cephem derivatives
URI et al.	1978	A rapid and simple method for detection of β-lactamase inhibitors
US4324890A (en)	1982-04-13	Cephalosporin intermediates
US4017487A (en)	1977-04-12	7β-(D-5-amino-5-carboxyvaleramido)-7-methoxy-3-substituted-3-cephem-4-carboxylic acid antibiotics
US4288590A (en)	1981-09-08	7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
CA1211730A (fr)	1986-09-23	Procede de preparation de sulfones de 3-hydroxymethyl cephalosporine
Saud et al.	2014	Synthesis of New Derivatves of β-Lactam Antibiotics
Essery et al.	1974	3-Acylthiomethyl cephalosporins